September 17, 2026 | AI, AI compliance, AI for life sciences, AI for pharma, HCP engagement, HCP training, Impetus Digital, KOL Engagement, Pharma trends, artificial intelligence, kol education, life sciences, patient engagement, pharma AI, webinar
Join Impetus Digital’s pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static programs into high-retention, interactive experiences without enterprise overhead.

While artificial intelligence has generated endless conversation across life sciences, moving from theoretical promise to practical execution remains a major hurdle for many teams. Designed specifically to cut through the industry noise, this pharma-exclusive webinar reveals how forward-thinking Medical Affairs, Med Ed, and Commercial leaders are deploying fully compliant, low-friction AI tools and interactive virtual workflows without incurring enterprise overhead or navigating complex open-web security risks.
Attendees will discover how to elevate static presentations and traditional learning modules into dynamic, high-retention environments—utilizing interactive AI presenters, dynamic scenario branching, and conversational AI peers like Ruby to transform passive participants into active, high-retention collaborators. Beyond showcasing creative, multi-departmental use cases and real-world client workflows, the session breaks down how to capture real-time market intelligence straight from live analytics dashboards—surfacing instant audience confidence scores, clinical knowledge gaps, and trending questions. Ultimately, this masterclass demystifies the adoption process, equipping agile life science teams with actionable best practices to boost knowledge retention by 4x, optimize project budgets, and achieve high-velocity outcomes.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Based on 13 years of experience in virtualizing life science meetings and events
Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches…
Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare…
A customer story
Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how…
Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into…
Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,…
John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical…
Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital…
Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and…
